胃癌分子分型与基因分型研究 消化内科 葛赛. 1. The sought to identify subtypes of gastric adenocarcinomas with particular biological properties and responses to chemotherapy.

Slides:



Advertisements
Similar presentations
2014 年 4 月研究生读书报告 王凯 硕士研究生 临床检验诊断学. Seminars In Cancer Biology A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
Advertisements

Zeroing in on Non-Small Cell Lung Cancer: Integrating Targeted Therapies into Practice.
Timosaponin A3 is a steroidal saponin from Anemarrhena asphodeloides that has a selective cytotoxic activity towards cancer cells Frank King, Sylvia Fong,
AB C Breast cancer Gas6 RNA Seq D E F Figure S1. AXL and GAS6 expression correlates with a mesenchymal signature. (A) Scatter plot representing the RNA.
Biomarker Analyses in CLEOPATRA: A Phase III, Placebo-Controlled Study of Pertuzumab in HER2- Positive, First-Line Metastatic Breast Cancer (MBC) Baselga.
Data Integration for Cancer Genomics. Personalized Medicine Tumor Board Question: given all we know about a patient, what is the “optimal” treatment?
Sino-Danish Breast Cancer Research Centre Beijing Genomic Institute, Shenzhen University of Copenhagen University of Århus University of Southern Denmark.
Hypoxia-inducible factors are required for
Network-based stratification of tumor mutations Matan Hofree.
Alizadeh et. al. (2000) Stephen Ayers 12/2/01. Clustering “Clustering is finding a natural grouping in a set of data, so that samples within a cluster.
Genomic signatures to guide the use of chemotherapeutics Authors: Anil Potti et. al Presenter: Jong Cheol Jeong.
Evaluating cell lines as tumor models by comparison of genomic profiles Domcke, S. et al. Nat. Commun 4:2126.
DNA Microarrays Examining Gene Expression. Prof. GrossBiology 4 DNA MicroArrays DNA MicroArrays use hybridization technology to examine gene expression.
1 Harvard Medical School Transcriptional Diagnosis by Bayesian Network Hsun-Hsien Chang and Marco F. Ramoni Children’s Hospital Informatics Program Harvard-MIT.
Margaret Tempero, M.D. Professor of Medicine University of California, San Francisco Debate: This house believes that FOLFIRINOX is the best treatment.
Advanced Cancer Topics Journal Review 4/16/2009 AD.
Dr. Ziad W Jaradat Cancer Stem Cells. Recently biologically distinct and relatively rare populations of tumor-initiating cells have been identified in.
KIF5B-RET fusions in lung adenocarcinoma The lab of technique department xueqiongZhai
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) in Non-Small Cell Lung Cancer (NSCLC) Victor.
Genomic Health, Inc. Yuko Soneoka, Ph.D., J.D. Senior Corporate Counsel, IP Director of Intellectual Property January 31, 2013.
IGF-1R: A key linker between chemoresistance and cancer stem cells in epithelial ovarian cancer cells Ram Kumar Singh, Ankit Jinager, Ajit Dhadwe, Abhijit.
Michael Birrer Ian McNeish New Developments in Biology and Targets of Epithelial Ovarian Cancer.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Array study discovery-driven Where is the hypothesis ?
+ Get Rich and Cure Cancer with Support Vector Machines (Your Summer Projects)
Breast Cancer and BRCA2. 1 million women worldwide diagnosed. 1 out of 12 women in Western Europe and the United States 30% mortality rate Highest cause.
Bioinformatics MEDC601 Lecture by Brad Windle Ph# Office: Massey Cancer Center, Goodwin Labs Room 319 Web site for lecture:
Prof. Yechiam Yemini (YY) Computer Science Department Columbia University (c)Copyrights; Yechiam Yemini; Lecture 2: Introduction to Paradigms 2.3.
Jin MENG Shen FU (DPD 08) Biology 2 - Head/Neck and CNS Tumors
Pan-cancer analysis of prognostic genes Jordan Anaya Omnes Res, In this study I have used publicly available clinical and.
A Discussion on Biologic Agents in Gastric Cancer Treatment Yoon-Koo Kang, MD Professor of Medicine Asan Medical Center University of Ulsan College of.
Clinicopathologic Features of EML4-ALK Mutant Lung Cancer Shaw AT et al. ASCO 2009; Abstract (Poster)
Personalized medicine in lung cancer R4 김승민. Personalized Medicine in Lung Cancer patients with specific types and stages of cancer should be treated.
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Gene Expression Signatures, Clinicopathological Features,
Introduction to Oncomine Xiayu Stacy Huang. Oncomine is a cancer-specific microarray database and has a web-based data-mining platform aimed at facilitating.
XXV^ Riunione Nazionale MITO Innovation in gynecologic cancer: optimal therapy, quality of life, precision medicine. Naples, June Targeting.
Samsung Genome Institute Samsung Medical Center
Precision Medicine: The Potential for Identifying Personalized Therapies for Patients with Gastro-Esophageal Cancer.
GENETIC BIOMARKERS.
高雄醫學大學附設醫院 外傷及重症外科 胃腸及一般外科
Transcriptional heterogeneity of breast cancer subtypes,
? miRNA profiling (primary vs recurrent) Between patients cohort (n=6)
Combination with IGF1R, PI3K inhibitors
Daniela Sia, Augusto Villanueva, Scott L. Friedman, Josep M. Llovet 
A New Path Forward: Immune Checkpoint Inhibitors in Bladder Cancer
A B C Supplementary figure S7
Volume 145, Issue 3, Pages (September 2013)
C. Allison Stewart, Lauren Averett Byers  Cancer Cell 
Volume 114, Issue 2, Pages (February 1998)
Daniela Sia, Augusto Villanueva, Scott L. Friedman, Josep M. Llovet 
Gene expression profiles as measured by the NanoString nCounter System in 54 patients with metastatic gastric cancer (GC). Gene expression profiles as.
Preclinical Accelerators of Precision Medicine Todd R. Golub, M.D.
Volume 141, Issue 2, Pages e11 (August 2011)
Volume 4, Issue 3, Pages (August 2013)
Figure 3 Examples of gene expression heterogeneity
Michael D. Brooks, Monika L. Burness, Max S. Wicha  Cell Stem Cell 
Personalized Medicine: Patient-Predictive Panel Power
Molecular prognostication of liver cancer: End of the beginning
Targeted Therapies for Hepatocellular Carcinoma
C. Allison Stewart, Lauren Averett Byers  Cancer Cell 
Volume 21, Issue 8, Pages (August 2013)
DNMT3A1 signatures are not recapitulated in AML.
Volume 26, Issue 12, Pages e5 (March 2019)
LATS2-associated gene expression pattern is down-regulated specifically in lumB breast tumors. LATS2-associated gene expression pattern is down-regulated.
Tyrosine kinase inhibitors
EGFR and cetuximab sensitivity of SCCUAT
CHCHD2 and EGFR protein expression in NSCLC
Frequently mutated genes in colorectal cancer.
Identification of putative TET1 targets in TNBC
Updates in Best Practices in Non-Small Cell Lung Cancer
Presentation transcript:

胃癌分子分型与基因分型研究 消化内科 葛赛

1. The sought to identify subtypes of gastric adenocarcinomas with particular biological properties and responses to chemotherapy and targeted agents is very popular in GC research these years. 2. By comparing gene expression patterns among 248 gastric tumors,this paper identified 3 major sub-types: proliferative, metabolic, and mesenchymal. 3. Tumors of the proliferative subtype had high levels of genomic instability, TP53mutations, and DNA hypomethylation. Cancer cells of the metabolic subtype were more sensitive to 5- fluorouracil than the other subtypes. Furthermore, in 2 independent groups of patients, those with tumors of the metabolic subtype appeared to have greater benefits with 5- fluorouracil treatment. Tumors of the mesenchymal subtype contain cells with features of cancer stem cells, and cell lines of this subtype are particularly sensitive to phos-phatidylinositol 3-kinase AKT mTOR inhibitors in vitro. 4 It is the first time using huge genome data to identify GC patients into subtypes related to threatments.

Gene signatures and KEGG and GO annotations for the 3 subtypes

(A, C) Consensus matrix (cophenetic correlation coefficient = 0.958) and distribution of average consensus indices without iterative feature selection. (B, D) Consensus matrix (cophenetic correlation coefficient = 0.987) and distribution of average consensus indices with iterative feature selection.

Cancer-specific survival of patients with and without 5-FU treatment.

THANKS FOR YOUR COMING